New study seeks to predict radiation success in nasopharyngeal cancer

NCT ID NCT07232680

First seen Nov 18, 2025 · Last updated May 04, 2026 · Updated 22 times

Summary

This study enrolls 500 adults with nasopharyngeal cancer who are receiving radiation (proton or photon) plus chemotherapy. Researchers will collect imaging scans and blood samples to find markers that predict how well the cancer responds, what side effects occur, and long-term outcomes. The goal is to better understand which treatment works best for each patient.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NASOPHARYNGEAL CANCINOMA (NPC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Chang Gung Memorial Hospital at Linkou

    RECRUITING

    Taoyuan City, Taiwan, 333, Taiwan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.